Skip to main content
Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
0.304
-0.001 (-0.39%)
Nov 21, 2024, 11:53 AM EST - Market open

Cara Therapeutics Revenue

Cara Therapeutics had revenue of $2.56M in the quarter ending September 30, 2024, a decrease of -47.47%. This brings the company's revenue in the last twelve months to $8.69M, down -59.08% year-over-year. In the year 2023, Cara Therapeutics had annual revenue of $20.97M, down -49.92%.

Revenue (ttm)
$8.69M
Revenue Growth
-59.08%
P/S Ratio
1.92
Revenue / Employee
$157,927
Employees
55
Market Cap
16.66M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202320.97M-20.90M-49.92%
Dec 31, 202241.87M18.84M81.81%
Dec 31, 202123.03M-112.05M-82.95%
Dec 31, 2020135.08M115.20M579.28%
Dec 31, 201919.89M6.42M47.64%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cumberland Pharmaceuticals 36.79M
Lifeward 25.00M
Ekso Bionics Holdings 17.68M
Kazia Therapeutics 1.66M
TherapeuticsMD 1.60M
Traws Pharma 226.00K
AIM ImmunoTech 190.00K
Revenue Rankings

CARA News

More News